SCHEMBL14770629

SCHEMBL14770629

c1cc(-c2cccc(-c3ccc4oc5ccc(-n6c7ccccc7c7ccccc76)cc5c4c3)n2)cc(-n2c3ccccc3c3ccccc32)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.38
ATM Q13315 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
PTPRF P10586 9/20 0.34
PTPN2 P17706 9/20 0.34
PTPN1 P18031 9/20 0.34
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
RAB9A P51151 2/20 0.33
SIRT2 Q8IXJ6 1/20 0.33
SIRT1 Q96EB6 1/20 0.33
CHEK2 O96017 1/20 0.33
CASP3 P42574 1/20 0.33
SENP7 Q9BQF6 1/20 0.33
SENP6 Q9GZR1 1/20 0.33
PLA2G2A P14555 3/20 0.32
PLA2G4A P47712 3/20 0.32
PLA2G10 O15496 1/20 0.32
NPC1 O15118 1/20 0.31
ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10041340 0.96 KDM4E (0.38) KDM4EATML3MBTL1PTPRFPTPN2
SCHEMBL14770715 0.94 L3MBTL1 (0.37) KDM4EATML3MBTL1PTPRFPTPN2
SCHEMBL14770569 0.94 KDM4E (0.38) KDM4EATML3MBTL1PTPRFPTPN2
SCHEMBL14770574 0.93 KDM4E (0.43) KDM4EATML3MBTL1PTPRFPTPN2
SCHEMBL14867943 0.93 KMT2A (0.38) KDM4EATML3MBTL1PTPRFPTPN2
SCHEMBL14770634 0.92 PRKDC (0.35) KDM4EATML3MBTL1PTPRFPTPN2
SCHEMBL14770645 0.92 KMT2A (0.37) KDM4EATML3MBTL1PTPRFPTPN2
SCHEMBL14770633 0.92 PRKDC (0.36) KDM4EATML3MBTL1PTPRFPTPN2
SCHEMBL20960179 0.90 PTPN1 (0.37) KDM4EL3MBTL1PTPRFPTPN2PTPN1
SCHEMBL2628372 0.90 KDM4E (0.44) KDM4EATML3MBTL1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9604972-B2 Nitrogen-containing heteroaromatic ring compound IDEMITSU KOSAN CO., LTD. (JP) 2017-03-28 US disclosed
US-9604972-B2 Nitrogen-containing heteroaromatic ring compound IDEMITSU KOSAN CO., LTD. (JP) 2017-03-28 US disclosed
US-20130062597-A1 NITROGEN-CONTAINING HETEROAROMATIC RING COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2013-03-14 US disclosed
US-20130062597-A1 NITROGEN-CONTAINING HETEROAROMATIC RING COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2013-03-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130062597-A1 NITROGEN-CONTAINING HETEROAROMATIC RING COMPOUND TDO2, AHR, NOC2L KDM4E 1763/4885ATM 1105/4885L3MBTL1 3163/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.